PRL and neoplasm: This might be explained considering that DA, mainly CAB, are generally effective in suppressing PRL levels and shrinking tumor mass in the vast majority of cases, with complete resistance occurring in 10% of patients with microprolactinoma and in less than 20% of those with macroprolactinoma treated with CAB (24).